New Australian government campaign to encourage further childhood vaccination

24 April 2017
australia_big

The Australian government is rolling out a new three-year A$5.5 million ($4.1 million) immunization awareness campaign to encourage Australian parents and carers to get their children vaccinated, the Department of Health and Ageing announced on Sunday.

While Australia’s immunization rates are already high, the government wants all Australian children fully vaccinated before they start school. Research shows that when people are fully informed about the benefits of vaccination, they are more likely to vaccinate.

The three-year campaign will specifically target areas of low vaccination rates by addressing myths and misconceptions, while explaining the benefits of childhood vaccinations for both the individual and the community. A range of advertising platforms combined with direct engagement at over 11,000 child care centers will be utilized to target parents of children aged under five years.

Vaccination works and the Turnbull government fully supports it as an effective and safe tool to prevent the spread of many diseases that cause hospitalization, serious ongoing health conditions and sometimes death.

While Australia’s national coverage is 93%, there are still some areas where it is as low as 64%. These pockets of low coverage pose risks to the community, especially people who cannot be immunized because they are too young or for medical reasons.

‘No Jab No Pay’ policy

This campaign will build on the incredibly successful ‘No Jab No Pay’ policy – which has seen around 200,000 extra children vaccinated since the start of last year.

And as part of this ‘No Jab No Play’ policy, the Prime Minister is calling on states and territories to ban unvaccinated kids from attending child care or pre-school services, and child care centers and pre-schools will be required to publish their vaccination coverage rates.

The only allowable exemption from vaccination will be for medical reasons.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical